Pancreatic Neoplasms: all 3,310 studies
Page 28 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesCompletedNCT01643499Phase 1
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
- Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic CancerCompletedNCT01628458Phase 2
- M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic CancerTerminatedNCT01621243Phase 1/2
- EUS Guided Celiac NeurolysisCompletedNCT01615653Not applicable
- The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without ErlotinibStatus unknownNCT01608841Phase 2
- A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002CompletedNCT01608711Phase 2
- Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic CarcinomaCompletedNCT01601808Phase 2
- Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic CancerWithdrawnNCT01598584Phase 2/3
- Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic CarcinomaCompletedNCT01593475Phase 2
- Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PBCompletedNCT01589328Not applicable
- Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP)CompletedNCT01587534Phase 2
- A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas CancerStatus unknownNCT01586611Phase 3
- Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic CancerActive, not recruitingNCT01580241
- BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic CancerCompletedNCT01571024Phase 1
- Double Bypass Versus Stent-treatment in Irresectable Pancreatic CancerWithdrawnNCT01569282Not applicable
- Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the PancreasStatus unknownNCT01563133Not applicable
- Postoperative Proton Radiotherapy With Chemo for Pancreatic CancerCompletedNCT01553019Phase 2
- Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic CancerCompletedNCT01547260Phase 1/2
- A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic CancerCompletedNCT01542177
- Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By SurgeryCompletedNCT01537107Phase 1
- Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially ResectableTerminatedNCT01531712Phase 2
- Contrast Enhanced Endoscopic Ultrasound for Vascular Involvement in Pancreatic LesionsWithdrawnNCT01526590Not applicable
- Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic NeoplasmTerminatedNCT01525706Phase 1
- Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1WithdrawnNCT01524575Phase 2
- T-EUS for Gastrointestinal Disorders: A Multicenter RegistryStatus unknownNCT01522573
- NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic CancerCompletedNCT01521702Phase 3
- A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.WithdrawnNCT01510561Phase 1
- A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine TreatmentStatus unknownNCT01509911Phase 2
- Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic CancerCompletedNCT01505413Phase 2
- Standard Versus Fanning Techniques for Endoscopic Ultrasound-Fine Needle Aspiration (EUS-FNA)CompletedNCT01501903Not applicable
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary CancersCompletedNCT01497392Phase 1
- Pilot Study of Meat-Borne Carcinogens and Pancreatic CancerCompletedNCT01492907Phase 1
- Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic CancerCompletedNCT01488552Phase 1/2
- Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer PatientsCompletedNCT01487785Phase 1
- VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic CancerCompletedNCT01486329Phase 1
- LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic CancerCompletedNCT01485744Phase 1
- 18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the PancreasCompletedNCT01485679Not applicable
- Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUSCompletedNCT01479803Phase 3
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic CancerWithdrawnNCT01473303Phase 1/2
- A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic AdenocarcinomaCompletedNCT01472198Phase 2
- Extracolonic Findings on Computed Tomography (CT) ColonographyStatus unknownNCT01465425
- Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer PatientsTerminatedNCT01461915Phase 2
- Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic CancerCompletedNCT01458717Phase 2/3
- Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic CarcinomaCompletedNCT01456585Phase 1
- Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic TumorsTerminatedNCT01455311
- Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic TargetsCompletedNCT01454180Phase 2
- Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)Status unknownNCT01448668
- Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic CancerCompletedNCT01446458Phase 1
- Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic CancerCompletedNCT01442974Not applicable
- Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter RegistryStatus unknownNCT01439698
- TKM 080301 for Primary or Secondary Liver CancerCompletedNCT01437007Phase 1
- Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic CancerWithdrawnNCT01434550Not applicable
- Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary OriginTerminatedNCT01434459Phase 1
- Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic CancerCompletedNCT01430052Phase 2
- Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)CompletedNCT01420874Phase 1
- Ketogenic Diet With Concurrent Chemoradiation for Pancreatic CancerTerminatedNCT01419483Not applicable
- Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryCompletedNCT01416662Phase 2
- FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic AdenocarcinomaCompletedNCT01413022Phase 1
- Distal Pancreatectomy With Partial Splenectomy for Pancreatic TumorsWithdrawnNCT01412684
- Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas CancerStatus unknownNCT01411072Not applicable
- Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable TumoursCompletedNCT01397019Phase 2
- Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic CancerCompletedNCT01396681Phase 2
- Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic CancerCompletedNCT01396668Phase 2
- Strength Training on Pancreatic CancerWithdrawnNCT01395563Not applicable
- Biospecimens for Identification of Diseases of the Pancreas.CompletedNCT01392027Not applicable
- On-site Cytopathology EUS-FNACompletedNCT01386931
- CT-011 and p53 Genetic Vaccine for Advanced Solid TumorsWithdrawnNCT01386502Phase 1
- SOM 230 and Gemcitabine in Advanced Pancreatic CancerCompletedNCT01385956Phase 1
- Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio ImmunotherapyCompletedNCT01384253Phase 1
- FOLFIRINOX Plus IPI-926 for Advanced Pancreatic AdenocarcinomaCompletedNCT01383538Phase 1
- Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic CancerStatus unknownNCT01372735Phase 1/2
- Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor ConspicuityWithdrawnNCT01371240Early Phase 1
- NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic CancerCompletedNCT01369420Phase 2
- Early (4 Days) Versus Standard Drainage of the Abdominal Cavity After PancreaticoduodenectomyCompletedNCT01368094Not applicable
- New Treatment Option for Pancreatic CancerCompletedNCT01364805Phase 1
- Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic CancerTerminatedNCT01362582Phase 3
- Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic CancerCompletedNCT01360853Phase 3
- Prospective Study Comparing Methods of Obtainment of Specimen After EUS-FNA in Patients With Peri-pancreatic MassCompletedNCT01354795Not applicable
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsCompletedNCT01352962Phase 1
- Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line ChemotherapyCompletedNCT01339754Phase 2
- Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic CancerCompletedNCT01335958Phase 1
- Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic CancerTerminatedNCT01335945Phase 1
- Valproic Acid With Chemoradiotherapy for Pancreatic CancerStatus unknownNCT01333631Phase 2
- Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas CancerStatus unknownNCT01333332Phase 2
- Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic CarcinomaTerminatedNCT01333124Phase 2
- L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)SuspendedNCT01330823Phase 3
- Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic CancerCompletedNCT01327794
- Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical ResectionTerminatedNCT01326364
- Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Cephalic DuodenopancreatectomyStatus unknownNCT01324856Phase 1
- Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic CancerTerminatedNCT01314027Phase 3
- Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic CancerCompletedNCT01304160Phase 1/2
- Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01303029Phase 2
- Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the PancreasCompletedNCT01298401Phase 1
- Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic CancerCompletedNCT01298011Phase 2
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTerminatedNCT01282333Phase 1
- Prognostic Score To Predict Major Complications After PancreaticoduodenectomyCompletedNCT01278381
- Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic CancerCompletedNCT01272791Phase 2
- Neoadjuvant FDR GX in Locally Advanced Pancreatic CancerCompletedNCT01268384Phase 2
- HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)Status unknownNCT01266720Phase 1